Kimia Biosciences Ltd.
Snapshot View

39.00 -0.10 ▼-0.3%

16 August 2022, 04:01:00 PM
Volume: 996

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kimiabiosciences.com
Market Cap 184.52 Cr.
Enterprise Value(EV) 225.09 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -0.78 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 32.02 Trailing Twelve Months Ending 2022-03
Book Value / Share 3.15 Trailing Twelve Months Ending 2022-03
Price to Book Value 12.39 Calculated using Price: 39.00
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 4.73 Cr. 47,312,741 Shares
FaceValue 1
Company Profile
The company is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.26%
1 Week
-6.02%
1 Month
+7.88%
3 Month
+1.83%
6 Month
-11.96%
1 Year
-16.22%
2 Year
+12.39%
5 Year
+76.87%
10 Year
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 62.28 -34.59 -166.09 243.83 16.47 32.19
Return on Capital Employed (%) 43.72 -23.86 -135.77 -216.82 -18.30 11.83 16.94 8.94 16.13
Return on Assets (%) 20.12 -13.60 -33.62 -92.83 -11.72 4.76 6.24 1.83 5.31

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 3 2 0 -4 -5 2 6 13 18 15
Non Curr. Liab. 1 1 1 7 9 25 29 34 37 32
Curr. Liab. 2 2 3 1 7 31 30 39 51 62
Minority Int.
Equity & Liab. 6 6 5 4 12 58 65 86 107 109
Non Curr. Assets 4 4 4 4 10 15 18 25 35 36
Curr. Assets 2 1 1 1 2 43 48 61 72 73
Misc. Exp. not W/O
Total Assets 6 6 5 4 12 58 65 86 107 109

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 12 6 2 0 1 76 94 106 133 131
Other Income 0 0 1 0 1 1 1 1 2 1
Total Income 12 7 2 0 2 77 95 107 135 132
Total Expenditure -10 -7 -4 -4 -2 -74 -88 -102 -124 -129
PBIDT 2 0 -1 -3 0 3 7 5 11 3
Interest 0 0 0 -1 0 -1 -2 -3 -3 -4
Depreciation 0 0 0 0 0 -1 -1 -2 -2 -3
Taxation 0 0 0 0 0 0 0 0 0 1
Exceptional Items
PAT 1 -1 -2 -4 -1 2 4 1 5 -3
Adjusted EPS 2 -1 -2 -5 -1 1 3 0 1 -1

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 2 1 1 0 -6 -1 -7 -3 0 6
Cash Fr. Inv. -1 -1 0 0 0 -6 -2 -2 -9 -14
Cash Fr. Finan. -1 -1 0 0 6 7 10 4 8 8
Net Change 0 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 1 0 0 1

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 74.94 74.94 74.94 74.94 74.94 74.94 74.94 74.94 74.94
Public 25.06 25.06 25.06 25.06 25.06 25.06 25.06 25.06 25.06
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 16 Aug 2022
Submission Of Newspaper Cuttings Of Financial Results For The Quarter And Three Months Ended On June 30 2022
Dear Sir Pursuant to Regulation 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith a copy of unaudited Financial Results (Standalone) for the quarter and three months ended June 30 2021 as published in Financial Express (English) and Jansatta (Hindi) on August 13 2022 duly considered and approved by the Board of Directors in its meeting held on Friday August 12 2022 at 4:00 p.m (IST) at corporate office of the Company.Kindly take the above information on your record.
Fri, 12 Aug 2022
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Dear Sir/ Maam Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that that Ms. Arti Chief Financial Officer of Kimia Biosciences Limited (theCompany) has resigned from the Company with effect from 12"" August 2022 due to her personalreasons. The Requisite disclosure required in pursuance of SEB] Circular CIR/CFD/CMD/4/2015 dated09 September 2015 is annexed herewith.The new Chief Financial Officer will be appointed in due course of time by the Company.
Fri, 12 Aug 2022
Board Meeting Outcome for Board Outcome Along With Un-Audited Standalone Financial Results For The Quarter And Three Months Ended June 30 2022
The meeting of Board of Directors of the Company was held today on Friday August 12 2022 at 4.00 P.M IST at the Corporate Office of the Company situated at 974 9th Floor Aggarwal Millennium Tower-II Netaji Subhash Place Pitam Pura New Delhi-110034.

Technical Scans View Details >>

Fri, 12 Aug 2022
High Delivery Percentage High Delivery Percentage
High Increase 1 Month High Increase 1 Month
Doji and Near Doji Doji and Near Doji
Bullish Harami Cross Bullish Harami Cross
Thu, 11 Aug 2022
High Delivery Percentage High Delivery Percentage

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 914.60 +0.1%
Divi's Laboratories Ltd. 98,918.90 3,732.00 +0.2%
Cipla Ltd. 82,906.37 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. 51,917.53 1,569.90 +2.0%
Piramal Enterprises Ltd. 45,855.65 1,926.70 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 33.32 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,926.70 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 3.86 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,926.70 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,926.70 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,926.70 +0.3%

FAQ's On Kimia Biosciences Ltd.

Can I Buy Kimia Biosciences Shares now?

What is the Share Price of Kimia Biosciences?

What is the Relative Strength Index (RSI) Value of Kimia Biosciences?

What is the Market Capital (MCAP) of Kimia Biosciences?

What are the key metrics to analyse Kimia Biosciences?

What is the Price Performance of Kimia Biosciences?